MediWound Announces $25M Strategic Private Placement Financing Of 1.45M Shares At $17.20/Share To Advance EscharEx Pre-Commercial Activities
Portfolio Pulse from Benzinga Newsdesk
MediWound Ltd. (NASDAQ:MDWD) announced a $25M strategic private placement financing of 1.45M shares at $17.20/share to advance EscharEx pre-commercial activities. The funds will be used for development and manufacturing capabilities for EscharEx and general corporate purposes.
July 15, 2024 | 11:09 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
MediWound Ltd. has secured $25M through a private placement to advance the pre-commercial activities of EscharEx. The funds will also support the development of large-scale manufacturing capabilities and general corporate purposes.
The $25M financing will provide MediWound with the necessary capital to advance EscharEx, a key product in their pipeline. This is likely to be viewed positively by investors as it supports the company's growth and development plans.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100